Atlas Trials

Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma

Clinical trial NCT07333430 · RECRUITING

Trial details

NCT number
NCT07333430
Sponsor
Hadassah Medical Organization
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed/Refractory Multiple Myeloma (MM)
Start date
2026-01-15
Primary completion
2027-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.